Censo Biotechnologies

Censo Bio operates as a specialist Contract Research Organization (CRO) with a focus on complex cell biology, particularly in the realms of human neurodegenerative, neuroinflammatory, and inflammatory disease models. The company leverages its expertise in induced pluripotent stem cell (iPSC) technology to develop assays that are crucial for drug development, especially in modeling cytokine release. Censo Bio's services are tailored for pharmaceutical and biotechnology companies seeking to advance their research in neurobiology and inflammation. By providing detailed characterization of cell phenotypes, including cell surface receptor expression, Censo Bio ensures high confidence in assay results. The business model revolves around offering specialized research services that facilitate the development of therapeutic solutions, thereby generating revenue through collaborative projects and service contracts.

Keywords: CRO, cell biology, neurodegenerative, neuroinflammatory, inflammatory, iPSC, cytokine release, drug development, pharmaceutical, biotechnology.